These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9637431)

  • 41. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a 55-bp deletion in the glucocerebrosidase gene in Gaucher disease: phenotypic presentation and implications for mutation detection assays.
    Mao R; O'Brien JF; Rao S; Schmitt E; Roa B; Feldman GL; Spence WC; Snow K
    Mol Genet Metab; 2001 Mar; 72(3):248-53. PubMed ID: 11243731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Giant lymphadenopathy infiltrated by gaucher cells mimicking lymphoma.
    Yağci B; Salor O; Yalçin B; Gürakan F; Güçer S; Büyükpamukçu M
    Pediatr Blood Cancer; 2009 Jul; 52(7):870-1. PubMed ID: 19213078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of 12 new mutations in Gaucher disease Brazilian patients.
    Rozenberg R; Fox DC; Sobreira E; Pereira LV
    Blood Cells Mol Dis; 2006; 37(3):204-9. PubMed ID: 17059888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Biochemical and molecular diagnosis of Gaucher disease in Tunisia].
    Dandana A; Ferchichi S; Khedhiri S; Chkioua L; Jaidane Z; Monastiri K; Ben Khelifa S; Ben Mansour R; Maire I; Froissart R; Bonnet V; Laradi S; Miled A
    Ann Biol Clin (Paris); 2007; 65(6):647-52. PubMed ID: 18039610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New insights into the origin of the Gaucher disease-causing mutation N370S: extended haplotype analysis using the 5GC3.2, 5470 G/A, and ITG6.2 polymorphisms.
    Rodríguez-Marí A; Díaz-Font A; Chabás A; Pastores GM; Grinberg D; Vilageliu L
    Blood Cells Mol Dis; 2001; 27(5):950-9. PubMed ID: 11783960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gaucher disease.
    Butters TD
    Curr Opin Chem Biol; 2007 Aug; 11(4):412-8. PubMed ID: 17644022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
    Sawkar AR; Adamski-Werner SL; Cheng WC; Wong CH; Beutler E; Zimmer KP; Kelly JW
    Chem Biol; 2005 Nov; 12(11):1235-44. PubMed ID: 16298303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gaucher disease, a paradigm for single gene defects.
    Beutler E
    Experientia; 1995 Mar; 51(3):196-7. PubMed ID: 7698272
    [No Abstract]   [Full Text] [Related]  

  • 50. Look before you leap. Carrier screening for type 1 Gaucher disease: difficult questions.
    Borry P; Clarke A; Dierickx K
    Eur J Hum Genet; 2008 Feb; 16(2):139-40. PubMed ID: 18043719
    [No Abstract]   [Full Text] [Related]  

  • 51. Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and "modifier" polymorphisms.
    Montfort M; Chabás A; Vilageliu L; Grinberg D
    Hum Mutat; 2004 Jun; 23(6):567-75. PubMed ID: 15146461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Molecular genetic analysis of neurologic diseases].
    Tsuji S; Tanno Y; Yoneda M
    Hum Cell; 1990 Dec; 3(4):318-22. PubMed ID: 1710491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of nonsense-mediated mRNA decay in mutant alleles identified in Spanish Gaucher disease patients.
    Montfort M; Chabás A; Vilageliu L; Grinberg D
    Blood Cells Mol Dis; 2006; 36(1):46-52. PubMed ID: 16326120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gaucher disease and parkinsonism.
    Sidransky E
    Mol Genet Metab; 2005 Apr; 84(4):302-4. PubMed ID: 15781189
    [No Abstract]   [Full Text] [Related]  

  • 55. Gaucher disease type 2: homozygosity for the mutation F331S in two unrelated consanguineous Muslim Arab patients with Gaucher disease from the Gaza and Jenin regions.
    Baris HN; Raas-Rothschild A; Garty BZ; Tor R; Klontz S; Tayebi N; Sidransky E; Cohen IJ
    Blood Cells Mol Dis; 2011 Dec; 47(4):262-3. PubMed ID: 21889374
    [No Abstract]   [Full Text] [Related]  

  • 56. Three unrelated Gaucher's disease patients with three novel point mutations in the glucocerebrosidase gene (P266R, D315H and A318D).
    Walley AJ; Ellis I; Harris A
    Br J Haematol; 1995 Oct; 91(2):330-2. PubMed ID: 8547070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Picture in clinical hematology no. 67].
    Rinsho Ketsueki; 2013 Nov; 54(11):2023. PubMed ID: 24305533
    [No Abstract]   [Full Text] [Related]  

  • 58. Rare compound heterozygosity for IVS2 +1G>A and R170P in an Italian patient with Gaucher disease type 1.
    Concolino D; Mussari A; Filocamo M; Strisciuglio P
    Clin Genet; 2003 Sep; 64(3):261-2. PubMed ID: 12919144
    [No Abstract]   [Full Text] [Related]  

  • 59. Simplified detection of Nci mutation in Gaucher disease.
    Dahl N; Lagerström M; Erikson A; Pettersson U
    Lancet; 1990 Jun; 335(8705):1589-90. PubMed ID: 1972504
    [No Abstract]   [Full Text] [Related]  

  • 60. Glucocerebrosidase mutation T369M appears to be another polymorphism.
    Walker JM; Lwin A; Tayebi N; LaMarca ME; Orvisky E; Sidransky E
    Clin Genet; 2003 Mar; 63(3):237-8. PubMed ID: 12694238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.